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Abstract 
Introduction 
Patients admitted to intensive care following surgery for faecal peritonitis present particular 
challenges in terms of clinical management and risk assessment. Collaborating surgical and 
intensive care teams need shared perspectives on prognosis. We aimed to determine the 
relationship between dynamic assessment of trends in selected variables and outcomes. 
Methods 
We analysed trends in physiological and laboratory variables during the first week of ICU 
stay in 977 patients from 102 centres across 16 European countries. The primary outcome 
was 6-month mortality. Secondary end-points were ICU, hospital and 28 day mortality. For 
each trend, Cox proportional hazards (PH) regression analyses, adjusted for age and gender, 
were performed for each endpoint. Trends remaining significant after Bonferroni correction 
for multiple testing were entered into a multivariate Cox PH model to determine independent 
associations with mortality. 
Results 
Trends over the first 7 days ICU stay independently associated with 6 month mortality were 
worsening thrombocytopaenia (mortality HR = 1.02, 95% CI 1.01-1.03, p < 0.001) and renal 
function (total daily urine output HR = 1.02, 95%CI 1.01-1.03, p < 0.001; renal SOFA sub-
score HR = 0.87, 95%CI 0.75-0.99, p = 0.047), maximum bilirubin level (HR = 0.99, 95%CI 
0.99-0.99, p = 0.02) and GCS SOFA sub-score (HR = 0.81, 95%CI 0.68-0.98, p = 0.028). 
Changes in renal function (total daily urine output and renal component of the SOFA score), 
GCS component of the SOFA score, total SOFA and worsening thrombocytopaenia were also 
independently associated with secondary outcomes (ICU, hospital and 28 day mortality). We 
detected the same pattern when analysing trends on days 2, 3 and 5. 
Dynamic trends in all other measured laboratory and physiological variables and in 
radiological findings failed to be retained as independently associated with outcome on 
multivariate analysis. Furthermore, changes in respiratory support, renal replacement therapy 
and inotrope and/or vasopressor requirements were not independently associated with any of 
the primary or secondary outcomes. 
Conclusions 
Only deterioration in renal function, thrombocytopaenia and SOFA score over the first 2, 3, 5 
and 7 days ICU stay were consistently associated with mortality at all endpoints. These 
findings may help to inform clinical decision making in patients with this common cause of 
critical illness. 
Introduction 
Patients admitted to intensive care following surgery for faecal peritonitis present particular 
challenges in terms of clinical management and risk assessment. Collaborating surgical and 
intensive care teams need shared perspectives on trends in illness severity and likely 
outcomes. Dynamic assessment of trends and the response to treatment, including evaluation 
of changes in laboratory tests and dependence on organ support, may be more informative 
than isolated initial measurements when assessing the prognosis of individual patients. 
Several methods have been evaluated for dynamic assessment of critically ill patients [1-4]; 
including those undergoing surgery, and some have examined dynamic changes in patients 
with peritonitis [5-9], but the burden of data collection is considered by many to be a 
deterrent to routine use [10] and one study found that existing scoring systems were 
inadequate for this purpose [9]. These studies are, however relatively small; the largest 
reported data on 163 patients only. 
Given the paucity of data on the association between trends in clinical variables during the 
early stages of ICU admission following surgical intervention for FP and outcomes, we have 
used a large international database of FP patients, with the aim of analysing trends in all 
available clinical variables during the first week of ICU stay and their relationship to 
outcome. 
Intra-abdominal infections and, in particular, FP, although affecting all age groups, are 
conditions which typically affect the elderly. The severity of sepsis, and the likelihood of an 
adverse outcome, are both reflected in persisting organ system failures, and may be 
aggravated by limited physiologic reserve, the presence of comorbidities, and impaired 
wound healing [11,12]. With an ageing population, the incidence of FP is likely to increase, 
adding pressure on already scarce healthcare resources [13,14]. In this setting detecting trends 
in key laboratory and physiological variables, and in the severity of organ dysfunction could 
prove useful in supporting decision making with regards to escalating, limiting or 
withdrawing treatment and might help reduce variability in critical care decision-making 
[15]. 
GenOSept (Genetics Of Sepsis and Septic Shock in Europe) is a pan-European part-FP6-
funded study conceived by the European Critical Care Research Network of the European 
Society for Intensive Care Medicine to investigate the potential impact of genetic variation on 
the host response and outcomes in sepsis [16]. To date the GenOSept cohort includes the 
largest and diagnostically most homogeneous collection of clinical data on critically ill 
patients with faecal peritonitis (FP). We recently reported outcome analyses from this cohort, 
based on data from day 1 of admission to the intensive care unit (ICU) [12]. 
Material and methods 
Recruitment 
Ethics approval was granted either nationally and/or locally (for individual centres - see 
Additional file 1). Written, informed consent for inclusion in the GenOSept study was 
obtained from all patients or a legal representative. The study was performed in accordance 
with the ethical standards laid down in the 1964 Declaration of Helsinki and its later 
amendments. Patients were recruited from 102 centres across 16 European countries (see 
Additional file 1 for contributors) between September 2005 and January 2011. 
The definition of sepsis was based on the International Consensus Criteria: “the clinical 
syndrome defined by the presence of both infection and a systemic inflammatory response” 
[17]. Patients were followed for up to 6 months from enrolment, or until death. 
Inclusion criteria: adult patients (>18 years) admitted to a High Dependency Unit or Intensive 
Care Unit (ICU) with faecal peritonitis (FP). FP was defined as inflammation of the serosal 
membrane that lines the abdominal cavity, secondary to contamination by faeces, as 
diagnosed at laparotomy. 
Exclusion criteria: peritonitis due to gastric or upper GI-tract perforation (e.g. gastric or 
duodenal ulcer perforation, terminal ileum perforation), patient or legal representative 
unwilling or unable to give consent; patient pregnant; advanced directive to withhold or 
withdraw life sustaining treatment or admitted for palliative care only; patient already 
enrolled in an interventional research study of a novel/unlicensed therapy (patients enrolled in 
interventional studies examining the clinical application or therapeutic effects of widely 
accepted, “standard” treatments, were not excluded); patient immuno-compromised (known 
regular systemic corticosteroid therapy, exceeding 7 mg/kg/day of hydrocortisone or 
equivalent, within three months of admission and prior to acute episode, known regular 
therapy with other immunosuppressive agents, e.g. azathioprine, known to be HIV positive or 
have acquired immunodeficiency syndrome as defined by the Centre for Disease Control, 
neutrophil count less than 1000 mm-3 due to any cause, including metastatic disease and 
haematological malignancies or chemotherapy, but excluding severe sepsis; organ or bone 
marrow transplant receiving immuno-suppressive therapy). 
Database and quality assurance 
See Additional file 1. 
Statistical analysis 
Clinical data of FP patients recruited to GenOSept were collected on days 1,2,3,5 and 7 of 
ICU stay, including all variables required to calculate admission APACHE (Acute 
Physiology and Chronic Health Evaluation) II and daily SOFA (Sequential Organ Failure 
Assessment) scores [18,19]. We used investigator coded presence (or absence) of acute renal 
failure (ARF): the study was started before the international definitions of acute kidney injury 
had been developed. 
Data extracted from the electronic case report form (eCRF) for the purposes of this analysis 
pertained to the first week of ICU admission. The trends were calculated as linear change 
over the first week (obtained by subtracting the value on day 1 from the value on day 7), as a 
prospectively chosen summary measure for the primary analysis. The use of summary 
measures, to combine data obtained at multiple time points for the same individual, is a 
recommended statistical procedure; using such a measure allowed the identification of a 
general trend over the first week of ICU stay, while also avoiding common pitfalls in the 
analysis of serial measurements [20]. 
The primary study outcome was 6-month mortality. Secondary end-points were ICU, hospital 
and 28 day mortality. We also evaluated shorter term trends by subtracting the values on day 
1 from the values on days 2, 3 and 5. 
We analysed trends in all 35 variables where data were available for the first week of ICU 
stay. For each trend, Cox proportional hazards (PH) regression analyses, adjusted for age and 
gender, were performed for each endpoint. Trends found to be significant in these analyses, 
after Bonferroni correction for multiple testing (p value < 0.00143 = 0.05/35 to take account 
of the 35 variables tested) were entered into a multivariate Cox PH model, to identify the 
factors independently associated with mortality, adjusting for potential confounding factors. 
The full list of variables whose trends were tested is provided in Additional file 1. 
Statistical analyses were performed using R version 2.11.1 (The R Project for Statistical 
Computing [21] and STATA statistical software (STATA 10.1, StataCorp, Lakeway Drive, 
College Station, Texas 77845 USA [22]. 
Results 
Between 29 September 2005 and 5 January 2011, 977 patients with a diagnosis of FP 
confirmed at laparotomy were recruited to the GenOSept cohort. 
The median age was 69.2 (IQR 58.3–77.1) years; 54.3 % were male; 98.6 % of patients were 
Caucasian. The median ICU and hospital length of stay (LOS) were 10 days (IQR 5–21), and 
28 days (IQR 15–51), respectively. The median APACHE II score was 16 (IQR 12–21). Of 
these 977 patients, 187 (19.1%) had died at 28 days, 204 (20.9%) died during their ICU stay, 
283 (28.7%) died in hospital and 309 (31.6%) had died at 6 month follow-up. Other 
admission characteristics for the GenOSept FP cohort were described in our previous 
publication [12]. 
Of 977 patients, 937 patients stayed in ICU for at least 2 days, hence they could be included 
in the analysis of dynamic trends; of the remaining 40 (4.1%), 11 died on day 1 and 29 were 
discharged alive from ICU on day 1 (of whom 21 were alive at 6 months and 8 were censored 
alive at hospital discharge). Also 321 individuals did not have data for day 7; 237 did not 
have data at day 5 and 107 did not have data at day 3, (either because they had died or they 
had been discharged alive from ICU). 
Table 1 describes trends in clinical variables between day 1 and day 7 of ICU stay (for values 
related to days 2, 3 and 5 see Additional file 1: Table S1). During the observed period, the 
proportion of patients suffering with acute renal failure (ARF) decreased from 29.1% (283 of 
974) to 24.1% (159 of 659), the proportion of those receiving ventilatory support (as CPAP - 
Continuous Positive Airways Pressure - or invasive mechanical ventilation) fell from 76.3% 
(743 of 974) to 62.9% (413 of 657), while the proportion of those receiving any inotropic 
and/or vasopressor therapy decreased from 72.6% (707 of 974) to 34.2% (226 of 660). The 
median (IQR, interquartile range) SOFA score decreased from 7 (5-10) to 5 (2-8), mainly due 
to a decrease in the cardiovascular and renal components. 
Table 1 Trends in variables during first 7 days ICU stay 
Day Day 1 Day 7
Characteristics N n or Mediana % or IQRb N n or Mediana % or IQRb 
Organ failure and support       
ARF 974 283 29.1 659 159 24.1 
RRT 974 115 11.8 659 104 15.8 
Ventilatory support 974 743 76.3 657 413 62.9 
Inotropes/vasopressors use* 974   660   
     None  267 27.4  434 65.8 
     A  33 3.4  36 5.5 
     B  169 17.4  105 15.9 
     C  505 51.9  85 12.9 
SOFA 974 7a 5-10b 659 5a 2-8b 
GCS SOFA 974 0a 0-1b 674 0a 0-1b 
CVS SOFA 974 4a 1-4b 671 1a 0-3b 
Coagulation SOFA 974 0a 0-1b 674 0a 0-1b 
Respiratory SOFA 974 2a 2-3b 659 2a 1-3b 
Renal SOFA 974 1a 0-2b 674 0a 0-1b 
Bilirubin SOFA 974 0a 0-1b 674 0a 0-0b 
Laboratory variables       
Serum bicarbonate 893 21a 18-24b 580 26a 23-29.1b 
paO2 (kPa) 945 11.3a 9.6-13.9b 590 10.8a 9.2-13.6b 
paCO2 (kPa) 938 5.2a 4.6-6b 535 5.2a 4.7-6b 
Highest creatinine (μmol/l) 974 106.6a 76-160b 654 81.5a 53.9-132b 
Lowest creatinine (μmol/l) 974 100a 70-144b 642 81.5a 54-130b 
Highest WCC (10-9/l) 974 12a 7.1-18b 643 15.3a 11-20.4b 
Lowest WCC (10-9/l) 974 9.4a 4.6-15b 643 15a 10.5-20b 
Lowest platelets (10-9/l) 974 212.5a 145-300b 640 234.5a 132-352.5b 
Highest bilirubin (mmol/l) 974 13a 8-22b 650 10a 5-19b 
Highest urea (mmol/l) 908 11a 6.4-17.1b 607 11.6a 7.2-20.8b 
Chest radiography findings      
Localised infiltrates 973 115 11.8 672 68 10.1 
Lobar infiltrates 973 61 6.3 672 32 4.8 
Diffuse bilateral infiltrates 973 148 15.2 672 109 16.2 
Physiological parameters    
Highest temperature (°C) 974 37.7a 37-38.3b 656 37.4a 37-38b 
Lowest temperature (°C) 974 36.2a 35.7-36.9b 656 36.5a 36-37b 
Highest SBP (mmHg) 974 140a 125-155b 655 150a 135-170b 
Lowest SBP (mmHg) 972 90a 80-100b 655 108a 95-120b 
Highest MAP (mmHg) 972 91a 82-103b 649 98a 89-110b 
Lowest MAP (mmHg) 970 62a 56-70b 649 71a 63-80b 
Highest Heart Rate (bpm) 974 117a 103-130b 655 104a 90-118b 
Lowest Heart Rate (bpm) 971 85a 73-99b 655 80a 70-90b 
Respiratory rate (breath/minute) 966 18a 14-24b 638 20a 16-27b 
Urine volume (ml/24 hours) 973 1375a 790-2100b 644 2276.5a 1333.5-3411.5b 
P:F ratio (kPa) 942 27.8a 19.6-37.7b 573 30.7a 23.1-39.2b 
n, absolute count; IQR, interquartile range; N, number of non-missing observations; SOFA, Sequential Organ 
Failure Assessment; GCS, Glasgow Coma Scale; ARF, Acute Renal Failure; RRT, Renal Replacement Therapy; 
CVS, cardiovascular; paO2, arterial partial pressure of oxygen; paCO2, arterial partial pressure of carbon 
dioxide; WCC, White Cell Count; SBP, Systolic Blood Pressure; MAP, Mean Arterial Pressure; bpm, beats per 
minute; P:F, ratio of partial pressure arterial oxygen and fraction of inspired oxygen. 
aMedian and bIQR are shown instead of absolute count (n) and percentage (%). 
*Inotropic and vasopressors use was coded as follows: A = Dopamine ≤ 5 μg/kg/min or Dobutamine, B = 
Dopamine > 5 μg/kg/min or adrenaline/noradrenaline ≤0.1 μg/kg/min, C = Dopamine > 15 μg/kg/min or 
adrenaline/noradrenaline > 0.1 μg/kg/min. 
Table 2 shows the estimated hazard ratios (HRs) for the primary and secondary endpoints for 
trends in variables that were significant after adjusting for multiple testing in individual 
variable analyses and after inclusion in multivariate analyses. 
Table 2 Factors independently associated with 6 month, ICU, hospital and 28 day 
mortality, after adjustment for age and gender 
Variable Unit HR 95% CI p value
6 month mortality     
Deterioration of thrombocytopaenia 10 x 10-9/l platelets 1.02 1.01-1.03 <0.001
Decrease in daily urinary volume 100 ml 1.02 1.01-1.03 <0.001 
Decrease in highest recorded bilirubin mmol/l 0.99 0.99-0.99 0.020 
Improvement in GCS SOFA 1 point 0.81 0.68-0.98 0.028 
Improvement in renal SOFA 1 point 0.87 0.75-0.99 0.047 
ICU mortality     
Decrease in daily urinary volume 100 ml 1.02 1.01-1.03 0.005
Improvement in total SOFA 1 point 0.91 0.85-0.98 0.009 
Hospital mortality     
Deterioration of thrombocytopaenia 10 x 10-9/l platelets 1.02 1.01-1.03 0.001 
Decrease in daily urinary volume 100 ml 1.02 1.01-1.03 <0.001 
Improvement in GCS SOFA 1 point 0.8 0.68-0.95 0.011 
Improvement in renal SOFA 1 point 0.87 0.77-0.99 0.043 
28 day mortality     
Decrease in daily urinary volume 100 ml 1.02 1.01-1.03 0.001 
Improvement in GCS SOFA 1 point 0.75 0.61-0.93 0.010 
Improvement in renal SOFA 1 point 0.79 0.66-0.95 0.013
SOFA, Sequential Organ Failure Assessment, SBP, Systolic Blood Pressure; CPAP, Continuous Positive 
Airways Pressure; CXR, chest radiography; RRT, Renal Replacement Therapy; GCS, Glasgow Coma Score; 
SBP, Systolic Blood Pressure; HR, Hazard Ratio; CI, confidence interval. 
The trends in variables over the first 7 days ICU stay that remained significantly and 
independently associated with 6 months outcome were worsening thrombocytopaenia and 
renal function (total daily urine output and renal component of the SOFA score), highest 
recorded level of bilirubin and GCS component of the SOFA score. 
Changes in renal function (total daily urine output and renal component of the SOFA score), 
GCS component of the SOFA score, total SOFA and worsening thrombocytopaenia were also 
independently associated with secondary outcomes. 
Dynamic trends in all other measured laboratory and physiological variables and in 
radiological findings failed to be independently associated with outcome on multivariate 
analyses. Furthermore, changes in respiratory support, renal replacement therapy and 
inotrope and/or vasopressor requirements appeared not to be independently associated with 
any of the primary or secondary outcomes. 
Figure 1 displays trends over the first week of ICU admission in the five variables 
independently associated with 6 month outcome (thrombocytopaenia, daily urinary volume, 
renal and GCS components of the SOFA score, serum bilirubin concentration). Survivors and 
non-survivors displayed differences in both absolute values and trends in these variables 
during their ICU stay. The platelet count remained consistently lower throughout the 
observation period and decreased more markedly in non-survivors compared to survivors. 
The daily total urine output was consistently greater and increased more markedly in 
survivors compared to non-survivors, throughout the 7 days (Table 3). The highest measured 
bilirubin showed an improvement during the 7 days observation period in survivors, but not 
in non-survivors. The GCS component of the SOFA score for non-survivors tended to be 
initially worse and to deteriorate further during the observation period, while the renal 
component of the SOFA scores tended to be consistently worse in non-survivors. 
Figure 1 Trends in variables independently associated with 6 month survival (primary 
outcome). Sections A1-A3. Daily lowest platelet count, 24 hour urinary volume, highest 
recorded bilirubin concentration. The boxes indicate median and inter-quartile range, the 
whiskers extend to include 1.5 x IQR, dots include outliers outside this range. Sections B1-
B2. Daily GCS and renal components of the SOFA score. Proportions of different values of 
the renal and GCS components of the SOFA are indicated for survivors and non-survivors. 
Table 3 Trends during first 7 days ICU stay (in survivors and non-survivors at six 
months) for variables which were independently associated with outcomes at 
multivariate analyses 
Day Day 1 Day 7
Characteristics N n or Mediana % or IQRb N n or Mediana % or IQRb
Lowest platelets (10-9/l)       
Survivors 667 226a 159-316b 426 267a 164-388b 
Non-survivors 307 185a 113-280b 214 146a 78-274b 
Urine volume (ml/24 hours)       
Survivors 666 1499a 916-2170b 429 2460a 1680-3633b 
Non-survivors 307 1080a 475-1915b 215 1750a 471-2774b 
Highest bilirubin (mmol/l)       
Survivors 667 13a 8-21b 433 9a 5-17b 
Non-survivors 307 14a 8-25b 217 14a 6-25b 
GCS SOFA       
Survivors 667 0a 0-0b 453 0a 0-0b 
Non-survivors 307 0a 0-2b 221 1a 0-2b 
Renal SOFA       
Survivors 667 0a 0-1b 453 0a 0-1b 
Non-survivors 307 1a 0-3b 221 1a 0-3b 
n, absolute count; IQR, interquartile range; N, number of non-missing observations; SOFA, Sequential Organ 
Failure Assessment; GCS, Glasgow Coma Scale. 
aMedian and bIQR are shown instead of absolute count (n) and percentage (%). 
The analyses of trends over the first 2, 3 and 5 days yielded similar results. The trends over 
the first 48 hours ICU stay independently associated with outcomes were deteriorating 
thrombocytopaenia and renal function (urinary output and renal SOFA score) and total SOFA 
score (Additional file 1: Table S2). The trends over the first 3 days ICU independently 
associated with outcomes were thrombocytopaenia, renal function (urinary output and renal 
SOFA score), total SOFA score and, for 28 day mortality only, GCS SOFA score, MAP and 
P:F ratio (Additional file 1: Table S3). The trends over the first 5 days ICU independently 
associated with outcomes were thrombocytopaenia, renal function (urinary output, renal 
SOFA score and highest recorded serum urea) and total SOFA score (Additional file 1: Table 
S4). 
Discussion 
This large, prospectively gathered, diagnostically homogeneous and rigorously quality 
assured European cohort provides an unique opportunity to examine associations between 
trends in clinical variables and short and long term outcomes of post-operative FP patients 
admitted to ICUs. 
In our study, the trends most strongly associated with mortality in all the analyses, were 
worsening thrombocytopaenia and renal dysfunction, the SOFA score and in particular the 
GCS and renal components of the SOFA score. 
Two studies, published as conference abstracts, have specifically evaluated outcomes of 
critically ill FP patients, reporting different mortality rates [23]. Sayer et al. have reported in-
hospital mortality rates of 21.6% and 38.1%, for the malignancy and non-malignancy sub-
groups respectively [23,24], while Pawa et al. reported 30 day mortality rates of 46% for 
patients aged <75 years and 78% for patients aged > 75 years, suggesting that different local 
practices of critical care admission, periods considered, evolution in concurrent treatments 
and underlying characteristics of the populations (other than admission diagnosis) may have 
influenced results. None of the studies reported microbiological isolates or the relationship 
between trends in clinical variables and outcomes. Pawa and co-workers report age as the 
strongest outcome predictor, while Sayer and colleagues suggests that hypo-albuminaemia 
and the presence of malignancy influence mortality [24].Other studies have evaluated 
heterogeneous populations of patients with peritonitis of multiple aetiologies, with several 
different predictors identified, depending on the patient case mix [9,25,26]. 
Worsening thrombocytopaenia 
In our cohort worsening thrombocytopaenia over the first 7 days ICU stay was found to be 
independently associated with the primary (6 month mortality) and two of the secondary 
outcomes (hospital and 28-day mortality). Thrombocytopaenia is a common finding 
following operative intervention for intra-abdominal sepsis, and a falling platelet count has 
been reported to be useful for distinguishing infected from non-infected peritonitis [27]. 
Thrombocytopenia is also a marker of disease severity, co-administration of blood products 
and development of consumption coagulopathy. A strong link between poor outcome of 
critically ill patients and both low absolute platelet counts and the development of and/or 
worsening thrombocytopaenia has also been previously reported in various patient 
populations [28-32]. In the study by Vanderschueren and colleagues in an unselected 
population of intensive care patients the development of thrombocytopaenia and a reduction 
from baseline of 50% or more in platelet count had more explanatory power for ICU 
mortality than admission variables [28]. A study by Williamson et al. examined the effects of 
prevalent and incident thrombocytopenia in an unselected population of over 20000 critically 
ill patients, demonstrating an independent association of low platelet counts with mortality. 
This association was stronger for specific admission diagnoses, in particular for the cancer, 
respiratory, digestive, genitourinary, and infectious categories [29]. In the study by Strauss et 
al. a decrease in platelet count ≥30% was significantly linked to higher mortality in 145 
unselected critically ill patients [30]. A prospective observational study by Sharma et al. 
evaluated the incidence of various degrees of severity of thrombocytopenia in 69 septic shock 
patients, concluding that thrombocytopenia is associated with worse clinical outcomes in this 
unselected population of critically ill patients [31]. Crowther et al. also found that the 
development of thrombocytopaenia was strongly associated with mortality in 261 unselected 
critical care patients [32]. 
Deteriorating renal function 
In the GenOSept FP cohort worsening renal function was consistently found to be associated 
with a higher mortality at all time points. Although there is still some debate as to whether the 
excess mortality observed with renal dysfunction simply reflects the severity of the 
underlying illness, or whether renal dysfunction independently contributes to poorer survival, 
the retention of this relationship on multivariate analysis suggests that the development of 
acute kidney injury directly contributes to worse outcomes. Impaired renal function has also 
been linked to impaired immune function [33-36]. In the study by Barrantes et al. of 496 
critically ill patients, the mortality rate of patients with acute kidney injury (AKI) was 
significantly higher than those without [33]. Ostermann et al. examined the effect of AKI on 
over 22000 adult general ICU patients, and found that the AKI classification correlated with 
outcome [34]. A study by the same author, conducted in an unselected ICU population of 
almost 42000 patients, examined the criteria for acute renal injury (ARI), acute renal failure 
syndrome (ARFS) and severe acute renal failure syndrome (SARFS), and found that 
worsening degrees of renal impairment correlated with mortality [35]. Mehta et al. studied 
611 unselected ICU patients, highlighting the higher incidence of sepsis amongst those with 
AKI [36]. 
Deteriorating SOFA 
While the SOFA score was originally conceived as a tool for describing the evolution of 
dysfunction in various organs, rather than to predict outcome, we found that trends in the 
global SOFA, and in specific components (renal and GCS), were closely associated with 
mortality [19]. Our findings are comparable with those from a recently reported prospective 
observational cohort study, investigating the systems that most contribute to the development 
of multiple organ system failure (MOSF). This study of 102 patients with abdominal sepsis 
highlighted the importance of trends in the SOFA score, demonstrating how the value on day 
4 (as opposed to admission SOFA) had a high precision in predicting 28 day mortality, with 
MOSF being mainly contributed to by renal, central nervous and respiratory system 
dysfunction [5]. Another study of 62 critically ill patients with post-operative peritonitis, 
demonstrated the importance of trends in SOFA scores calculated serially over a 5 day post-
operative period to distinguish between patients with or without persistent post-operative 
intra-abdominal sepsis [6]. A prospective observational study of 56 secondary peritonitis 
patients measured several inflammatory parameters and multiple severity scoring systems 
pre-operatively and over a 5 days post-operative period, in a serial fashion. This study 
showed that combining the SOFA scores with measurement of serum neopterin concentration 
(a specific cellular immune system activation marker) and TNF (Tumour Necrosis Factor) 
receptor II levels yielded the highest predictive sensitivities and specificities for pre- and 
post-operative outcomes [7]. In a study of 163 consecutive ICU patients with secondary 
peritonitis, hospital mortality was accurately predicted by the post-operative SOFA score [8]. 
In a large trial comparing on-demand versus planned relaparotomy for severe peritonitis, the 
SOFA score showed good discriminatory power to predict hospital mortality, although it was 
unable to predict the need for re-laparotomy [9,37]. In a retrospective cohort study by Sumi et 
al. both the SOFA and POSSUM scores were able to risk stratify patients undergoing surgical 
intervention for colorectal perforation [38]. 
Mulier et al. have also previously reported the influence of coma on mortality in a study of 
generalized post-operative peritonitis patients, independently of age and source control [39]. 
Similarly, Matsumura et al. studied 218 general medical and surgical ICU patients, and 
showed that serum procalcitonin levels and SOFA score at ICU discharge could predict post-
ICU mortality and survival time [40]. Jones et al. studied 248 emergency department patients 
with severe sepsis and evidence of hypoperfusion at presentation, concluding that the SOFA 
score had prognostic value for in-hospital survival [41]. 
Hyperbilirubinaemia 
Post-operative hyperbilirubinaemia has been linked to persistent post-surgical infection and a 
poor prognosis [42]. In a study of patients with peritonitis, hyperbilirubinaemia, together with 
age and organ/system failures, was found to be amongst a number of mortality predictors on 
univariate analysis [43]. 
Although the hazard ratios presented in Table 2 are small, the larger the change in the 
underlying variable, the larger the effect (proportionally) on mortality. For example a 
reduction in platelet count of 50 (*10-9/l) is associated with a hazard ratio for 6 month 
mortality of 1.10 (95% confidence interval of 1.05-1.16, p < 0.001), indicating a 10% 
increase in risk of death at 6 months. Similarly, a reduction in 24 hour urine output of just 
500 ml is associated with a hazard ratio for 6 month mortality of 1.09 (95% confidence 
interval 1.04-1.14, p < 0.001), which translates into a 9% increase in risk of death. Such 
trends are therefore potentially relevant to the practicing clinician and will contribute to 
bedside assessment of severity of illness in patients with FP. 
Limitations 
The main limitation of our study is the potential for unmeasured factors to confound the 
associations detected. Subsequent prospective studies specifically aimed at confirming the 
potential predictive accuracy of the trends identified here would be required to further assess 
their value in clinical practice. The overwhelming majority of patients enrolled in this study 
were Caucasian and, therefore, caution should be exercised when extrapolating these findings 
to different ethnic populations. Our findings are applicable to FP patients who stayed in ICU 
for at least 2 days, although only 40 (4.1%) of the 977 FP patients in this cohort had a shorter 
stay, hence we consider it unlikely that this would have generated significant bias. 
Conclusions 
In this large and homogeneous cohort of critically ill patients with FP admitted to European 
ICUs, we have shown that changes in routinely measured, readily available at the bedside, 
clinical, physiological and laboratory parameters are associated with outcome. Only 
deterioration in renal function, thrombocytopaenia and SOFA score over the first 2,3 5 and 7 
days were consistently associated with mortality. Other laboratory variables, radiological 
findings, physiological parameters or even changes in respiratory support, renal replacement 
therapy and inotrope and/or vasopressor requirements, as analysed here over multiple time 
intervals, appeared not to be independently and consistently associated with any of the 
primary or secondary outcomes. 
Patients displaying deteriorating trends in these key clinical variables may be prospectively 
identified as at higher mortality risk. External validation of the predictive power of the trends 
identified here would clarify to what extent detection of such trends could be relied upon to 
inform clinical decision making. 
Key messages 
• In critically ill patients with faecal peritonitis only deterioration in renal function, 
thrombocytopaenia and SOFA score over the first 2,3 5 and 7 days were consistently 
associated with mortality 
• Other laboratory variables, radiological findings, physiological parameters or changes in 
respiratory support, renal replacement therapy and inotrope and/or vasopressor 
requirements were not independently associated with any of the primary or secondary 
outcomes 
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